Gedea Biotech develops an antibiotic-free treatment for vaginal infections, pHyph. Today, bacterial vaginosis (BV) is treated with antibiotics, but one out of two patients have a recurrent episode of BV within 90 days of treatment. pHyph restores the pH of the vagina to its natural level (4.0‒4.5), thus facilitating the re-establishment of the normal vaginal bacterial flora, and is expected to reduce the risk of recurrent BV and fungal infections.
Employees: 11-50
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Almi Inves... | almi.se |
Mentions in press and media 17
| Date | Title | Description | Source |
| 29.02.2024 | The Swedish femtech company Gedea Biotech selected for prest... | The Swedish femtech company Gedea Biotech selected for prestigious grant funding from the European I... | news.cisio... |
| 15.11.2023 | Gedea Biotech raises 1.5 MEUR (16.5 MSEK) in oversubscribed ... | Gedea Biotech raises 1.5 MEUR (16.5 MSEK) in oversubscribed rights issue as registration CL3-2 trial... | news.cisio... |
| 08.11.2023 | Gedea Biotech receives approval to initiate the pivotal NEFE... | Gedea Biotech receives approval to initiate the pivotal NEFERTITI-2 clinical study documenting the p... | news.cisio... |
| 13.09.2023 | Gedea Biotech granted European Patent for the formulation of... | Gedea Biotech granted European Patent for the formulation of its vaginal pHyph tablet for women with... | news.cisio... |
| 24.05.2023 | Gedea Biotech secures 1.3 MEuros (14 MSEK) to advance its an... | Gedea Biotech secures 1.3 MEuros (14 MSEK) to advance its antibiotic-free vaginal infection treatmen... | news.cisio... |
| 02.05.2023 | Gedea Biotech initiates EpHect Clinical Trial for Antibiotic... | Gedea Biotech initiates EpHect Clinical Trial for Antibiotic-free Treatment of Women with Vulvo Vagi... | news.cisio... |
| 18.04.2023 | Gedea Biotech obtains US-patent covering pHyph for antibioti... | Gedea Biotech obtains US-patent covering pHyph for antibiotic-free treatment and prevention of bacte... | news.cisio... |
| 12.04.2023 | Gedea Biotech appoints Anna-Karin Areskog as QA Director and... | Gedea Biotech appoints Anna-Karin Areskog as QA Director and receives ISO13485 certification Wed, Ap... | news.cisio... |
| 04.04.2023 | Gedea Biotech awarded SEK 3M from SWElife and MedTech4Health... | Gedea Biotech awarded SEK 3M from SWElife and MedTech4Health for groundbreaking antibiotic free wome... | news.cisio... |
| 18.05.2022 | Gedea Biotech to Start EpHect Clinical Trial for Antibiotic-... | Gedea Biotech to Start EpHect Clinical Trial for Antibiotic-free Treatment of Women with Vulvo Vagin... | news.cisio... |
Show more